CDRI’s new research hub in Lucknow to facilitate innovation in drug discovery & development

Lucknow:  Marking 70 years of its inception, the Central Drug Research Institute (CDRI) in Lucknow launched a new and advanced research facility called Common Research and Technology Development Hub (CRTDH). As per the motive behind its establishment, this centre would be aiding hospitals and pharmaceutical sector entities in conducting clinical tests and trials. Besides, the latest hub would also facilitate MSMEs and academia with an avenue for high-level research.

The representative from CDRI was quoted saying “CRDTH is not only for scientists but for institutions conducting advanced research in the field of drug discovery. CDRI will not only provide infrastructure support like high-end laboratories and equipment but also the expertise of our scientists.”

With the cutting edge research and development projects undertaken by the CSIR-CDRI, the world has been gifted with a wide range of low-cost efficient drugs and medicines. Amongst its innovative contributions to the drug industry, the most prominent names are Centchroman, the first non-steroidal oral contraceptive and Arteether, a lifesaving drug for cerebral malaria.

In addition to being a top-notch organisation for the development and manufacturing of drugs, CDRI has worked on multiple initiatives to upgrade the quality of elementary research and strengthen human resources.

The CRTDH was inaugurated along with the launch of Atal National Colloquium on Healthcare and Innovation. As a part of this flagship program, a number of renowned and eminent personalities will hold sessions and lectures. This program has been planned to honour the erstwhile Prime Minister Atal Vihari Bajpayee’s vision, that considered scientific development, the topmost priority. This event was also marked by the announcement of the coveted CDRI Awards-2021 for Excellence in Drug Research.

Related Posts

CCRAS committee reviews research programmes and future initiatives to strengthen Ayurveda research

The 106th meeting of the Internal Finance Committee (IFC) of the Central Council for Research in Ayurvedic Sciences (CCRAS) was held at the Regional Ayurveda Research Institute (RARI), Itanagar. The…

Maharashtra FDA increases medicine and cosmetics testing, flags 108 samples as non-compliant

Maharashtra’s Food and Drug Administration (FDA) has significantly increased laboratory testing of medicines and cosmetics, with 3,020 samples collected and 2,112 examined between June and August 2026. Of the drug…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

CCRAS committee reviews research programmes and future initiatives to strengthen Ayurveda research

CCRAS committee reviews research programmes and future initiatives to strengthen Ayurveda research

Maharashtra FDA increases medicine and cosmetics testing, flags 108 samples as non-compliant

Maharashtra FDA increases medicine and cosmetics testing, flags 108 samples as non-compliant

Assam: Drug inspector couple dismissed from service over bribery, disproportionate assets cases

Assam: Drug inspector couple dismissed from service over bribery, disproportionate assets cases

Health ministry strengthens allied and healthcare education and professional standards

Health ministry strengthens allied and healthcare education and professional standards

Siddhanta Super Speciality Hospital’s registration, licence cancelled in Bhopal: CMHO inspection finds 19 serious lapses from emergency to ICU; dialysis rules violated

Siddhanta Super Speciality Hospital’s registration, licence cancelled in Bhopal: CMHO inspection finds 19 serious lapses from emergency to ICU; dialysis rules violated

Chemist selling narcotics held, medical store sealed

Chemist selling narcotics held, medical store sealed